Federal Circuit denies rehearing in ‘patent dance’ case

19-10-2015

Federal Circuit denies rehearing in ‘patent dance’ case

jiris / Shutterstock.com

The US Court of Appeals for the Federal Circuit has declined to hear the Amgen v Sandoz ‘patent dance’ dispute en banc.


US Court of Appeals for the Federal; Sandoz; Amgen; Novartis; biosimilars; patent dance; Zarxio; Neupogen; Biologics Price Competition and Innovation Act;

LSIPR